Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Japanese drugmaker Eisai closed down 2.3% at 5,587 yen today, despite news of regulatory approvals for two of its drugs.

Roberto Pili, MD, associate dean for cancer research and integrative oncology at the Jacobs School of Medicine and Biomedical Sciences, is the principal investigator on a new five-year, $1.8 million ...

The group of Jürgen Knoblich at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences, has ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

From Venom to The King in Black, Marvel has created dozens of symbiote Klyntar. But which of these alien weapons could be ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

Paste Magazine is your source for the best music, movies, TV, comedy, videogames, books, comics, craft beer, politics and ...

Throughlines in Scandinavian and Japanese design include clean lines, a strong connection to nature, minimalism and a ...

Be it garlicky, buttery or just a thick cut of bread, the Lone Star specialty has found a following in kitchens across the ...